Publications of Reinhard Hohlfeld
All genres
Journal Article (119)
2012
Journal Article
287 (25), pp. 20986 - 20995 (2012)
Target specificity of an autoreactive pathogenic human gamma delta-T cell receptor in myositis. The Journal of Biological Chemistry
Journal Article
209 (3), pp. 521 - 535 (2012)
Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration. Journal of Experimental Medicine
Journal Article
22 (5), pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
22, pp. 607 - 618 (2012)
Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed and paraffin embedded dissected autoptic multiple sclerosis lesions. Brain Pathology
Journal Article
18 (12), pp. 1743 - 1745 (2012)
Ion channels boost axonal injury in multiple sclerosis. Nature Medicine
Journal Article
4 (145), 145fs24 (2012)
β-Amyloid: Enemy or remedy? Science translational medicine: Integrating medicine and science
Journal Article
8 (11), pp. 613 - 623 (2012)
B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nature Reviews Neurology
Journal Article
319 (1-2), pp. 2 - 7 (2012)
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis. JOURNAL OF THE NEUROLOGICAL SCIENCES
Journal Article
79 (23), pp. 2241 - 2248 (2012)
Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology
Journal Article
18 (5), pp. 824 - 828 (2012)
Unbiased identification of target antigens of CD8(+) T cells with combinatorial libraries coding for short peptides. Nature Medicine 2011
Journal Article
179 (3), pp. 1347 - 1359 (2011)
Inclusion body myositis laser microdissection reveals differential up-regulation of IFN-gamma signaling cascade in attacked versus nonattacked myofibers. American Journal of Pathology
Journal Article
7 (1), pp. 56 - 59 (2011)
The emerging role of microRNAs in multiple sclerosis. Nature Reviews Neurology
Journal Article
17 (4), pp. 495 - 497 (2011)
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis. Multiple Sclerosis Journal
Journal Article
306 (1-2), pp. 180 - 182 (2011)
Humoral autoimmunity in multiple sclerosis. Journal of the Neurological Sciences
Journal Article
233 (1-2), pp. 245 - 248 (2011)
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin. Journal of Neuroimmunology
Journal Article
76 (15), pp. 1310 - 1315 (2011)
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology
Journal Article
77 (6), pp. 580 - 588 (2011)
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 2010
Journal Article
16 (12), pp. 1517 - 1520 (2010)
Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis. Multiple Sclerosis
Journal Article
88 (8), pp. 753 - 761 (2010)
Axo-glial antigens as targets in multiple sclerosis: Implications for axonal and grey matter injury. Journal of Molecular Medicine
Journal Article
16 (1), pp. 3 - 14 (2010)
'Gimme five': Future challenges in multiple sclerosis. ECTRIMS Lecture 2009. Multiple Sclerosis Journal
Journal Article
362 (5), pp. 387 - 401 (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. New England Journal of Medicine
Journal Article
20 (5), pp. 966 - 975 (2010)
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathology
Journal Article
133, pp. 2182 - 2184 (2010)
Beneficial brain autoimmunity? Brain
Journal Article
16 (4), pp. 376 - 377 (2010)
Molecular oracles for multiple sclerosis therapy. Nature Medicine
Journal Article
67 (4), pp. 422 - 424 (2010)
Zero Tolerance (to Acetylcholine Receptor) and Ways to Overcome It. Annals of Neurology 2009
Journal Article
106 (20), pp. 8302 - 8307 (2009)
Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
31 (4), pp. 467 - 477 (2009)
Novel approaches for identifying target antigens of autoreactive human B and T cells. Seminars in Immunopathology
Journal Article
39 (8), pp. 2036 - 2039 (2009)
Multiple sclerosis: Human model for EAE? European Journal of Immunology
Journal Article
132, pp. 3342 - 3352 (2009)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain
Journal Article
158 (3), pp. 1122 - 1132 (2009)
Neuro-immune crosstalk in CNS. Neuroscience
Journal Article
66 (5), pp. 655 - 658 (2009)
Cross-reactive T-Cell Receptors in Tumor and Paraneoplastic Target Tissue. Archives of Neurology 2008
Journal Article
197 (2), pp. 128 - 139 (2008)
BDNF and its receptors in human myasthenic thymus: Implications for cell fate in thymic pathology. Journal of Neuroimmunology
Journal Article
35 (7), pp. 345 - 355 (2008)
Autoantigen- und erregerspezifische T- und B-Zellreaktionen bei multipler Sklerose: „Eine unendliche Geschichte”? Aktuelle Neurologie
Journal Article
79 (6), pp. 716 - 719 (2008)
Open use of natalizumab. Neutralising antibodies and clinical data. Nervenarzt
Journal Article
70 (13 Pt 2), pp. 1155 - 1156 (2008)
TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome. Neurology
Journal Article
265 (1-2), pp. 93 - 96 (2008)
Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis? Journal of the Neurological Sciences
Journal Article
274 (1-2), pp. 5 - 8 (2008)
B- and T-cell responses in multiple sclerosis: Novel approaches offer new insights. Journal of Neurological Sciences
Journal Article
201-202, pp. 21 - 27 (2008)
Reflections on the "intrathymic pathogenesis" of myasthenia gravis. Journal of Neuroimmunology
Journal Article
4 (4), pp. 202 - 214 (2008)
Mechanisms of disease: Aquaporin-4 antibodies in neuromyelitis optica. Nature Clinical Practice Neurology
Journal Article
131, pp. 1455 - 1463 (2008)
Interferon-β increases BAFF levels in multiple sclerosis: Implications for B cell autoimmunity. Brain
Journal Article
71 (17), pp. 1350 - 1354 (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology
Journal Article
71, pp. 1812 - 1820 (2008)
Multiple sclerosis and the TNFRSF1A R92Q mutation: Clinical characteristics of 21 cases. Neurology
Journal Article
274 (1-2), pp. 42 - 44 (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis. Journal of Neurological Sciences
Journal Article
14 (6), pp. 688 - 693 (2008)
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nature Medicine
Journal Article
91 (Chapter 5), pp. 169 - 212 (2008)
The immunopathogenesis of myasthenia gravis. Handb Clin Neurol
Journal Article
255 (10), pp. 1449 - 1463 (2008)
Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations. Journal of Neurology 2007
Journal Article
68 (12), pp. 958 - 959 (2007)
Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology
Journal Article
69 (21), pp. 1966 - 1967 (2007)
Revisiting the immunopathogenesis of the inflammatory myopathies. Neurology
Journal Article
68 (3), pp. 58 - 63 (2007)
Dual role of inflammation in CNS disease. Neurology
Journal Article
109 (10), pp. 4376 - 4382 (2007)
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFα-dependent and Fc-receptor-independent way. Blood